Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Protein J ; 36(2): 77-97, 2017 04.
Artículo en Inglés | MEDLINE | ID: mdl-28258523

RESUMEN

Pelagia noctiluca is the most venomous jellyfish in the Mediterranean Sea where it forms dense blooms. Although there is several published research on this species, until now none of the works has been focused on a complete protein profile of the all body constituents of this organism. Here, we have performed a detailed proteomics characterization of the major protein components expressed by P. noctiluca. With that aim, we have considered the study of jellyfish proteins involved in defense, body constituents and metabolism, and furthered explore the significance and potential application of such bioactive molecules. P. noctiluca body proteins were separated by1D SDS-PAGE and 2DE followed by characterization by nanoLC-MS/MS and MALDI-TOF/TOF techniques. Altogether, both methods revealed 68 different proteins, including a Zinc Metalloproteinase, a Red Fluorescent Protein (RFP) and a Peroxiredoxin. These three proteins were identified for the first time in P. noctiluca. Zinc Metalloproteinase was previously reported in the venom of other jellyfish species. Besides the proteins described above, the other 65 proteins found in P. noctiluca body content were identified and associated with its clinical significance. Among all the proteins identified in this work we highlight: Zinc metalloproteinase, which has a ShK toxin domain and therefore should be implicated in the sting toxicity of P. noctiluca.; the RFP which are a very important family of proteins due to its possible application as molecular markers; and last but not least the discovery of a Peroxiredoxin in this organism makes it a new natural resource of antioxidant and anti-UV radiation agents.


Asunto(s)
Proteínas Luminiscentes/análisis , Metaloproteasas/análisis , Peroxirredoxinas/análisis , Proteoma/análisis , Escifozoos/metabolismo , Animales , Venenos de Cnidarios/análisis , Venenos de Cnidarios/química , Electroforesis , Proteínas Luminiscentes/química , Proteínas Luminiscentes/metabolismo , Mar Mediterráneo , Metaloproteasas/química , Metaloproteasas/metabolismo , Peroxirredoxinas/química , Peroxirredoxinas/metabolismo , Dominios Proteicos , Espectrometría de Masa por Ionización de Electrospray , Espectrometría de Masas en Tándem , Zinc , Proteína Fluorescente Roja
2.
BMC Complement Altern Med ; 13: 213, 2013 Aug 23.
Artículo en Inglés | MEDLINE | ID: mdl-23971790

RESUMEN

BACKGROUND: Hyaluronidases have been found as the target enzymes in the development of osteoarthritis (OA) disease. While there is still no curative treatment for this disease, recent studies on the treatment of OA were focused on the effectiveness of natural products which are expected to improve the symptoms with minimal side effects. The aim of this study was to screen selected Malaysian plants on their anti-hyaluronidase activity as well as to evaluate the active plant and its derived fractions on its potential anti-arthritic and antioxidant activities. METHODS: A total of 20 methanolic crude extracts (bark and leaf) from ten different plants were screened using a colorimetric hyaluronidase enzymatic assay. The active plant extract (Payena dasyphylla) was then studied for its hyaluronidase inhibitory activity in the interleukin-1ß (IL-1ß) stimulated human chondrocytes cell line (NHAC-kn) using zymography method. The Payena dasyphylla methanolic bark extract was then fractionated into several fractions in where the ethyl acetate (EA) fraction was evaluated for its inhibitory effects on the HYAL1 and HYAL2 gene expressions using reverse transcription-polymerase chain reaction (RT-PCR) technique. While the MMP-3 and MMP-13 protein expressions were evaluated using western blot method. The phenolic and flavonoid contents of the three fractions as well as the antioxidant property of the EA fraction were also evaluated. RESULTS: Bark extract of Payena dasyphylla (100 µg/ml) showed the highest inhibitory activity against bovine testicular hyaluronidase with 91.63%. The plant extract also inhibited hyaluronidase expression in the cultured human chondrocyte cells in response to IL-1ß (100 ng/ml). Similarly, treatment with Payena dasyphylla ethyl acetate (EA) fraction (100 µg/ml) inhibited the HYAL1 and HYAL2 mRNA gene expressions as well as MMP-3 and MMP-13 protein expression in a dose dependent manner. Payena dasyphylla EA fraction has demonstrated the highest amount of phenolic and flavonoid content with 168.62 ± 10.93 mg GAE/g and 95.96 ± 2.96 mg RE/g respectively as compared to water and hexane fractions. In addition, the Payena dasyphylla EA fraction showed strong antioxidant activity with IC50 value of 11.64 ± 1.69 µg/mL. CONCLUSION: These findings have shown that Payena dasyphylla might contained potential phenolic compounds that inhibiting the key enzyme in osteoarthritis development, which is the hyaluronidase enzyme through interruption of HYAL1 and HYAL1 gene expressions. The degradation of cartilage could also be inhibited by the plant through suppression of MMP-3 and MMP-13 protein expressions. We also reported that the inhibitory effect of Payena dasyphylla on hyaluronidase activity and expression might be due to its anti-oxidant property.


Asunto(s)
Condrocitos/efectos de los fármacos , Condrocitos/metabolismo , Hialuronoglucosaminidasa/metabolismo , Metaloproteasas/metabolismo , Extractos Vegetales/farmacología , Sapotaceae/química , Acetatos , Antioxidantes/química , Antioxidantes/farmacología , Compuestos de Bifenilo , Línea Celular , Células Cultivadas , Condrocitos/química , Flavonoides/análisis , Flavonoides/química , Humanos , Hialuronoglucosaminidasa/análisis , Hialuronoglucosaminidasa/antagonistas & inhibidores , Hialuronoglucosaminidasa/genética , Interleucina-1beta/farmacología , Metaloproteasas/análisis , Metanol , Picratos , Corteza de la Planta/química , Extractos Vegetales/química
3.
BMC Neurosci ; 13: 76, 2012 Jun 28.
Artículo en Inglés | MEDLINE | ID: mdl-22742423

RESUMEN

BACKGROUND: We investigated the use of a new MMP activatable probe MMPSense™ 750 FAST (MMPSense750) for in-vivo visualization of early MMP activity in ischemic stroke. Following middle cerebral artery occlusion (MCAO) optical imaging was performed. Near-infrared (NIR) fluorescent images of MMPSense activation were acquired using an Olympus fluorescent microscope, 1.25 x objective, a CCD camera and an appropriate filter cube for detecting the activated probe with peak excitation and emission at 749 and 775 nm, respectively. Images were acquired starting at 2 or 24 hours after reperfusion over the ipsilateral and contralateral cortex before and for 3 hours after, MMPSense750 was injected. RESULTS: Increased intensities ipsilaterally were observed following MMPSense750 injection with ischemic injury but not in sham animals. There were significant ipsilateral and contralateral differences at 15 minutes (P <0.05) in early ischemic reperfusion and at time 0 in 24 hours post ischemia (P <0.05) which persisted at 180 minutes in both these groups (P <0.01), but not following sham surgery. The increase in ipsilateral signal intensity was attenuated by hypothermia. These observations corresponded with a significant increase in the total MMP-9 protein levels, 5 and 24 hours following ischemia reperfusion (P <0.05) and their reduction by hypothermia. CONCLUSIONS: Matrix-metalloproteinase upregulation in ischemia reperfusion can be imaged acutely in-vivo with NIRF using MMPSense750. Hypothermia attenuated both the optical increase in intensity after MMPSense750 and the increase in MMP-9 protein expression supporting the proof of concept that NIRF imaging using MMPSense can be used to assess potential therapeutic strategies for stroke treatment.


Asunto(s)
Corteza Cerebral/metabolismo , Hipertermia Inducida/métodos , Infarto de la Arteria Cerebral Media , Rayos Infrarrojos , Metaloproteasas/análisis , Regulación hacia Arriba/fisiología , Análisis de Varianza , Animales , Corteza Cerebral/irrigación sanguínea , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Lateralidad Funcional , Infarto de la Arteria Cerebral Media/patología , Infarto de la Arteria Cerebral Media/fisiopatología , Infarto de la Arteria Cerebral Media/terapia , Flujometría por Láser-Doppler , Masculino , Metaloproteasas/metabolismo , Ratones , Ratones Endogámicos C57BL , Sondas Moleculares , Reperfusión , Factores de Tiempo
4.
Br J Anaesth ; 107(6): 844-58, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22065690

RESUMEN

The rapid detection and evaluation of patients presenting with perioperative neurological dysfunction is of great clinical relevance. Biomarkers have been defined as biological molecules that can be used as an indicator of new onset or progression of a biological process or effect of treatment. Biomarkers have become increasingly important in this setting to supplement other modalities of diagnosis such as EEG, sensory- or motor-evoked potential, transcranial Doppler, near-infrared spectroscopy, or imaging methods. A number of neuro-proteins have been identified and are currently under investigation for potential to provide insights into injury severity, outcome, and the ability to monitor cellular damage and molecular events that occur during neurological injury. S100B is a protein released by glial cells and is considered a marker of blood-brain barrier dysfunction. Clinical studies in patients undergoing cardiac and non-cardiac surgery indicate that serum levels of S100B are increased intraoperatively and after operation. The neurone-specific enolase has also been extensively investigated as a potential marker of neuronal injury in the context of cardiac and non-cardiac surgery. A third biomarker of interest is the Tau protein, which has been linked to neurodegenerative disorders. Tau appears to be more specific than the previous two biomarkers since it is only found in the central nervous system. The metalloproteinase and ubiquitin C terminal hydroxylase-L1 (UCH-L1) are the most recently researched markers; however, their usefulness is still unclear. This review presents a comprehensive overview of S100B, neuronal-specific enolase, metalloproteinases, and UCH-L1 in the perioperative period.


Asunto(s)
Metaloproteasas/análisis , Factores de Crecimiento Nervioso/análisis , Enfermedades del Sistema Nervioso/diagnóstico , Atención Perioperativa , Fosfopiruvato Hidratasa/análisis , Proteínas S100/análisis , Ubiquitina Tiolesterasa/análisis , Proteínas tau/análisis , Biomarcadores/análisis , Procedimientos Quirúrgicos Cardíacos , Puente Cardiopulmonar , Endarterectomía Carotidea , Humanos , Subunidad beta de la Proteína de Unión al Calcio S100
5.
Zhongguo Zhong Yao Za Zhi ; 36(24): 3511-4, 2011 Dec.
Artículo en Chino | MEDLINE | ID: mdl-22368868

RESUMEN

OBJECTIVE: To investigate the anticancer and anti-metastatic effect of Ajuga decumbens extraction (HBG) on breast cancer and to clarify the effect of HBG on MMPs and TIMPs. METHOD: The antitumor and antimetastic effect of HBG was determined using orthotopic 4T1 breast cancer mouse model. Western blot analysis was employed to detect the expression of associated proteins in breast cancer metastasis. RESULT: Administration with 50-200 mg x kg(-1) doses of HBG significantly reduced the tumor weight, tumor volume and numbers of lung tumor nodules in a dose-dependent manner. Tumor metastasis correlated proteins were altered following HBG treatment, MMP-2 and MMP-9 were down-regulated while TIMP-1 and TIMP-2 were up-regulated. CONCLUSION: HBG showed anticancer and antimetastatic effect towards breast cancer through regulating the expression of MMPs and TIMPs. These data sustain our contention that HBG might be used as a potential therapeutic agent.


Asunto(s)
Ajuga , Neoplasias Mamarias Experimentales/tratamiento farmacológico , Metaloproteasas/análisis , Metástasis de la Neoplasia/prevención & control , Fitoterapia , Extractos Vegetales/uso terapéutico , Inhibidores Tisulares de Metaloproteinasas/análisis , Animales , Femenino , Neoplasias Mamarias Experimentales/química , Neoplasias Mamarias Experimentales/patología , Metaloproteinasa 2 de la Matriz/análisis , Metaloproteinasa 9 de la Matriz/análisis , Ratones , Ratones Endogámicos BALB C , Invasividad Neoplásica , Inhibidor Tisular de Metaloproteinasa-1/análisis , Inhibidor Tisular de Metaloproteinasa-2/análisis
6.
Neuro Endocrinol Lett ; 28(2): 204-12, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17435663

RESUMEN

OBJECTIVE: Neuroblastoma (NB) is a well-known malignant disease in infants, which comprises 10% of childhood malignancies. Despite recent advances in understanding the neuro-oncology, NB still accounts for more death in childhood than any other cancer. Research in childhood tumors should not only be focused on the malignant signatures of cancer cells but also novel drug prototypes using phytochemicals. The present study was aimed to determine the role of curcumin against murine neuroblastoma cell line (N2a). METHODS: The in vitro assessment of curcumin against was made in N2a cell line in a dose-dependent manner (group I (control) and group II - IX (10 microM-80 microM). The efficacy of the drug was evaluated by estimating the levels of protein bound carbohydrates, glycoprotein, genomic DNA, total RNA levels, and inhibition of MMP-9 were studied. The gap junctional communication in the cells was also assessed. RESULTS: The levels of protein bound carbohydrates, DNA, RNA levels, glycoprotein were found to be altered on drug supplementation in NB cells. Inhibition of MMP-9 in curcumin-supplemented N2a cells was revealed by zymographic analysis. Assessment of Lucifer yellow dye uptake in curcumin-supplemented N2a cells showed the up-regulation of GJIC. CONCLUSIONS: These observations suggest that the curcumin, the active principle of curcuma longa, could be developed into an effective chemo preventive and chemotherapeutic agent. This selected concentration range needs further studies at molecular level, for conforming its role and its action against uncontrolled proliferation of NB.


Asunto(s)
Curcumina/farmacología , Neuroblastoma/patología , Animales , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , ADN de Neoplasias/análisis , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Uniones Comunicantes/química , Glicoproteínas/análisis , Metaloproteasas/análisis , Ratones , ARN Neoplásico/análisis , Azul de Tripano/farmacología
7.
Prikl Biokhim Mikrobiol ; 40(2): 194-200, 2004.
Artículo en Ruso | MEDLINE | ID: mdl-15125197

RESUMEN

When grown in a medium containing heat-stable potato tuber proteins, the oomycete Phytophthora infestans (Mont.) de Bary produces a set of exoproteinases active at neutral and mildly basic pH values. These extracellular proteinases have been shown by SDS-PAGE with the presence of gelatin to include at least six components differing in molecular weight. Inhibitory analysis and study of the effects of the enzymes on various synthetic substrates show that the culture liquid of P. infestans contains mainly serine proteinases specific to trypsin and subtilisin and metalloproteinases. Their activity is suppressed by proteinase-inhibitor proteins from potato tubers. It is suggested that P. infestans exoproteinases may be the metabolic target for natural proteinase inhibitors from potato.


Asunto(s)
Exopeptidasas/metabolismo , Phytophthora/enzimología , Medios de Cultivo , Exopeptidasas/química , Concentración de Iones de Hidrógeno , Metaloproteasas/análisis , Phytophthora/crecimiento & desarrollo , Proteínas de Plantas/metabolismo , Inhibidores de Serina Proteinasa/metabolismo , Solanum tuberosum/metabolismo , Especificidad por Sustrato , Subtilisina/análisis , Tripsina/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA